ERA-EDTA Award for Outstanding Basic Science Contributions to Nephrology

Olivier Devuyst

Olivier Devuyst, M.D., Ph.D., graduated from UCLouvain in Brussels (Belgium), trained in Brussels and at the Technion Institute (Haifa, Israel) and at the Johns Hopkins Medical School (Baltimore, USA). He is Full Professor of Medicine at the University of Zurich (Switzerland) and has a joint appointment in nephrology at Saint-Luc Academic Hospital in Brussels.

Dr. Devuyst and his group use a multi-level approach combining innovative disease models, deep phenotyping, and molecular and population genetics to investigate the mechanisms of solute and water transport in different cell types, and the pathophysiology of inherited kidney diseases. This joint work identified new mechanisms involved in rare genetic disorders affecting tubular cells and their relevance for kidney physiology. These findings substantiate the genetic architecture of kidney diseases and offer novel targets to treat common disorders including hypertension, kidney stones and urinary tract infections. In parallel, O. Devuyst demonstrated the crucial role of water channels (aquaporins) in peritoneal dialysis and he developed preclinical strategies to improve the efficiency of dialysis and to reduce structural damage in the peritoneal membrane.

O. Devuyst has authored more than 350 articles that are cited > 16’000 times. He is funded by national and international agencies including the EU and the NIH. Dr. Devuyst has been the laureate of several international prizes and is a Fellow of the Royal Academy of Medicine of Belgium. He is Associate Editor of Kidney International, Nephrology Dialysis Transplantation, and Orphanet Journal of Rare Diseases; and he serves in the Editorial Board of Clin J Am Soc Nephrol, Peritoneal Dialysis International, Frontiers in Physiology and Pflügers Archiv.

O. Devuyst coordinated several EU-funded research networks and has founded the Working Group on Inherited Kidney Disorders (WGIKD) of the ERA-EDTA in 2011. He was recognised as a Distinguished Fellow of the ERA-EDTA in 2013.

ERA-EDTA Award for Outstanding Clinical Contributions to Nephrology

Claudio Ronco

Claudio Ronco is Full Professor of Nephrology at the University of Padova and Director of the International Renal Research Institute of Vicenza and the Department of Nephrology, Dialysis and Transplantation of San Bortolo Hospital in Vicenza Italy.

Born in 1951, he graduated in Padova in 1976 and became a specialist in nephrology (Padova 1979) and pediatric nephrology (Naples 1986).

In 1999 and 2000 he acted as Director of the Renal Research Institute and Professor of Medicine at Albert Einstein College of Medicine in New York.

He is considered the father of Critical Care Nephrology and a pioneer in the field of Extracorporeal Therapies and Peritoneal Dialysis as well as the inventor of new devices such as CARPEDIEM (the miniaturized dialysis machine for neonates).

He is a recognised mentor for many physicians, engineers and scientists, given his capacity to bridge several disciplines such as medicine, physics, chemistry, engineering and design. Since 1982 he organises renown international courses in Vicenza attended by an international audience.

He authored 1530 papers, 1200 of them listed in Pub-Med, 82 books and 215 book chapters. He is honorary professor at the University of Virginia and Fudan & JaoTong Universities in Shanghai. He received an honorary degree in Medicine and Human Sciences at the University of Patras. He has received numerous awards including the Belding Scribner Award for hemodialysis, the Bywaters Award for AKI and the ESAO award for innovation. His H-index censored by Google Scholar is 106.

He is editor in Chief of 3 indexed journals: Cardiorenal Medicine, Blood Purification and Contributions to Nephrology. He is Editor Emeritus of the International Journal of Artificial Organs. He is Associate editor and editorial board member in several international journals including Nephrology Dialysis and Transplantation and Critical Care.

He is considered to be a polymath for his extensive knowledge and excellent capabilities.

ERA-EDTA Stanley Shaldon Award for Young Investigators

Rebecca Herzog

Rebecca Herzog is a translational researcher aiming to link omics-driven basic science and patient centred-clinical research in peritoneal dialysis. She received her PhD at the Medical University of Vienna in 2017. As research fellow of the Paediatric Nephrology Laboratory, in collaboration with Zytoprotec, a start-up spin-off company, she and her colleagues successfully developed a novel PD-fluid from experimental discovery to clinical application. As PostDoc at the “Christian Doppler Laboratory for Molecular Stress Research in PD” she now investigates molecular interventions to modulate cytoprotective mechanism in the dialysed peritoneal cavity. In her recent career Dr. Herzog discovered the role of a specific post-translational protein modification in PD, developed an immune-competence assay to clinical application and revealed the PD effluent proteome. She received 15 national and international awards and an ERA-EDTA short-term research fellowship. In 2019, Dr. Herzog has become a principal investigator in “IMPROVE-PD”, a new EU-Horizon2020 MSCA-ITN project.